Assessment of Immunological Parameters of Early Osteoporosis in Patients With Celiac Disease in Wasit Governorate

Authors

  • Fatima Yas Khudair Department of Biology, College of Education for pure Sciences, University of Wasit, Iraq
  • Nisreen Habib Al Moussaw Department of Biology, College of Education for pure Sciences, University of Wasit, Iraq

Keywords:

Osteoporosis, Immunological, Interleukin 6, Interleukin 18, Celiac Disease

Abstract

The study analyses the immunological markers, especially Interleukin-6 (IL-6) and Interleukin-18 (IL-18), in elderly Iraqi patients with early osteoporosis linked to coeliac disease (CD). Coeliac disease, an autoimmune condition induced by gluten, may adversely affect bone density via inflammatory and hormonal pathways. Seventy-five blood samples were collected: twenty-five from patients with osteoporosis and coeliac disease, and fifty from age- and sex-matched controls. The samples were categorised into two age groups (55–65 and 65–75 years) and assessed using ELISA methods for IL-6 and IL-18 concentrations. The research identified a statistically significant elevation (p < 0.001) in IL-6 and IL-18 concentrations in the patient cohort relative to the control group. Moreover, a notable gender-based disparity in IL-18 levels was observed, especially among female patients, indicating a hormonal impact on cytokine expression. These results highlight the potential of IL-6 and IL-18 as early immunological indicators for osteoporosis in people with coeliac disease. The findings support the use of immune profiling into clinical evaluations to enhance bone health management in coeliac patients. Additional longterm studies are required to elucidate causative pathways and assess the advantages of immunomodulatory treatments.

References

[1] F. Rahim, A. Zaki Zadeh, P. Javanmardi, T. E. Komolafe, M. Khalafi, A. Arjomandi, et al., “Machine learning algorithms for diagnosis of hip bone osteoporosis: A systematic review and meta-analysis study,” BioMedical Engineering OnLine, vol. 22, no. 1, p. 68, 2023.

[2] M. V. Machado, “New developments in celiac disease treatment,” International Journal of Molecular Sciences, vol. 24, no. 2, p. 945, 2023.

[3] A. Al-Toma, A. Herman, W. F. Lems, and C. J. Mulder, “The dietary and non-dietary management of osteoporosis in adult-onset celiac disease: current status and practical guidance,” Nutrients, vol. 14, no. 21, p. 4554, 2022.

[4] K. Skoracka, S. Hryhorowicz, F. Tovoli, A. Raiteri, A. M. Rychter, R. Słomski, et al., “Genetic, immunological, dietary, gut microbiota, and environmental determinants of osteoporosis in the course of celiac disease: Which factor plays the first violin in this orchestra?,” Calcified Tissue International, vol. 114, no. 2, pp. 98–109, 2024.

[5] J. Xiang, X. Zheng, L. Luo, and X. Yang, “Role of interleukin-18 in mediating the impacts of celiac disease on osteoporosis: a Mendelian randomization study,” Frontiers in Immunology, vol. 15, p. 1453657, 2024.

[6] M. L. Bianchi and M. T. Bardella, “Bone in celiac disease,” Osteoporosis International, vol. 19, pp. 1705–1716, 2008.

[7] A. Taranta, D. Fortunati, M. Longo, N. Rucci, E. Iacomino, F. Aliberti, et al., “Imbalance of osteoclastogenesis‐regulating factors in patients with celiac disease,” Journal of Bone and Mineral Research, vol. 19, no. 7, pp. 1112–1121, 2004.

[8] J. Xiang, X. Zheng, L. Luo, and X. Yang, “Mediating the impacts of celiac,” in Advances in the Pathogenesis and Treatment of Osteoporosis: From Bench to Bedside, p. 41, 2025.

[9] J. L. Pérez-Castrillón, M. Andres-Calvo, E. Izquierdo-Delgado, M. Mendo, D. de Luis, and A. Dueñas-Laita, “Celiac disease and osteoporosis: A review,” Open Bone Journal, vol. 1, pp. 23–27, 2009.

[10] A. V. Stazi, A. Trecca, and B. Trinti, “Osteoporosis in celiac disease and in endocrine and reproductive disorders,” World Journal of Gastroenterology, vol. 14, no. 4, pp. 498–504, 2008.

[11] E. Umur, S. B. Bulut, P. Yiğit, E. Bayrak, Y. Arkan, F. Arslan, et al., “Exploring the role of hormones and cytokines in osteoporosis development,” Biomedicines, vol. 12, no. 8, p. 1830, 2024.

[12] T. Larussa, E. Suraci, I. Nazionale, L. Abenavoli, M. Imeneo, and F. Luzza, “Bone mineralization in celiac disease,” Gastroenterology Research and Practice, vol. 2012, p. 198025, 2012.

[13] J. F. Ludvigsson, P. Green, and C. Ciacci, “Clinical management of celiac disease,” JAMA, vol. 323, no. 15, pp. 1517–1525, 2020.

[14] S. L. Crowe, L. P. Murray, and A. A. Barker, “Osteoimmunology and gut–bone axis in autoimmune diseases,” Frontiers in Immunology, vol. 13, p. 832765, 2022.

[15] M. Valentini, E. Zampella, and L. Iafusco, “The role of cytokines in bone remodeling in celiac disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 75, no. 4, pp. 512–518, 2022.

Downloads

Published

2025-07-23

How to Cite

Khudair, F. Y., & Al Moussaw, N. H. (2025). Assessment of Immunological Parameters of Early Osteoporosis in Patients With Celiac Disease in Wasit Governorate. Vital Annex: International Journal of Novel Research in Advanced Sciences (2751-756X), 4(7), 238–241. Retrieved from https://journals.innoscie.com/index.php/ijnras/article/view/98

Issue

Section

Articles